293 related articles for article (PubMed ID: 28229824)
1. Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine.
Kukuy O; Livneh A; Mendel L; Benor A; Giat E; Perski O; Feld O; Kassel Y; Ben-Zvi I; Lidar M; Holtzman EJ; Leiba A
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):32-37. PubMed ID: 28229824
[TBL] [Abstract][Full Text] [Related]
2. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
Sgouropoulou V; Stabouli S; Trachana M
Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and cardiovascular disease in familial Mediterranean fever. An analysis of hospital admissions for acute cardiovascular event.
Roitman A; Ben-Zvi I; Mendel L; Livneh A
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):80-85. PubMed ID: 30299242
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
[TBL] [Abstract][Full Text] [Related]
6. Cardiac disease in familial Mediterranean fever.
Erken E; Erken E
Rheumatol Int; 2018 Jan; 38(1):51-58. PubMed ID: 29051974
[TBL] [Abstract][Full Text] [Related]
7. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever.
Yildiz M; Masatlioglu S; Seymen P; Aytac E; Sahin B; Seymen HO
Can J Cardiol; 2006 Nov; 22(13):1127-31. PubMed ID: 17102830
[TBL] [Abstract][Full Text] [Related]
8. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
Erden A; Batu ED; Sarı A; Sönmez HE; Armagan B; Demir S; Fırat E; Bilginer Y; Bilgen SA; Karadağ Ö; Kalyoncu U; Kiraz S; Ertenli I; Özen S; Akdogan A
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
[TBL] [Abstract][Full Text] [Related]
9. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
10. Assessment of vascular damage in children and young adults with Familial Mediterranean Fever.
Vampertzi O; Papadopoulou-Legbelou K; Triantafyllou A; Koletsos N; Alataki S; Douma S; Papadopoulou-Alataki E
Rheumatol Int; 2022 Jan; 42(1):59-69. PubMed ID: 34739572
[TBL] [Abstract][Full Text] [Related]
11. Non-response to colchicine in familial Mediterranean fever should be identified accurately.
Melikoglu MA; Senel K
Int J Rheum Dis; 2017 Dec; 20(12):2118-2121. PubMed ID: 24702830
[TBL] [Abstract][Full Text] [Related]
12. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine.
Gemici AI; Sevindik ÖG; Akar S; Tunca M
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):57-9. PubMed ID: 24064015
[TBL] [Abstract][Full Text] [Related]
13. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P; Scaccianoce G; Palasciano G
Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
[TBL] [Abstract][Full Text] [Related]
14. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
Bonfrate L; Scaccianoce G; Palasciano G; Ben-Chetrit E; Portincasa P
Eur J Clin Invest; 2017 Sep; 47(9):622-629. PubMed ID: 28678379
[TBL] [Abstract][Full Text] [Related]
15. Biologic therapy in familial Mediterranean fever.
Koga T; Migita K; Kawakami A
Mod Rheumatol; 2016 Sep; 26(5):637-41. PubMed ID: 26939747
[TBL] [Abstract][Full Text] [Related]
16. Recurrent episodic fever. A presenting feature of familial Mediterranean fever.
Majeed HA; Rawashdeh M; Qubain H
J Med Liban; 1998; 46(1):12-5. PubMed ID: 9795516
[TBL] [Abstract][Full Text] [Related]
17. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
[TBL] [Abstract][Full Text] [Related]
18. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
19. Does Familial Mediterranean Fever Provoke Atherosclerosis in Children? Evaluation of Arterial Stiffness and Serum Endocan Levels.
Türkuçar S; Yıldız K; Küme T; Açarı C; Dundar HA; Makay B; Kır M; Ünsal E
Clin Rheumatol; 2021 Oct; 40(10):4199-4206. PubMed ID: 33813620
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
Erten S; Erten SF; Altunoglu A
Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
